Across TCGA pan-cancer cohorts, TAS2R41 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of TAS2R41’s most consistent transcriptional readouts.
The strongest signal is observed in lung squamous cell carcinoma (LUSC), where TAS2R41 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types TAS2R41 is over-expressed in tumor.
LUSC are the cancer types where TAS2R41 tumor–normal differential expression is most reproducible.